Dr. Scott R. Sherron, MD

Dr. Sherron practices at Houston Medical Center ASC in Houston, Texas.

Dr. Sherron's NPI, 1265403364, was assigned on January 28, 2006. Dr. Sherron graduated from Joe R. & Teresa Lozano Long School of Medicine in 1988. Dr. Sherron holds Texas license H6600.

Dr. Sherron's primary practice is Houston Medical Center ASC, at 6624 Fannin St, Houston, TX 77030 in Harris County. The practice phone is (832) 680-4680.

Dr. Sherron's primary practice is Houston Medical Center ASC in Houston, Texas. Dr. Sherron is also affiliated with Houston Methodist Hospital. Dmand AI also links Dr. Sherron to 2 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherron practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Sherron's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Sherron is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Sherron is licensed in Texas.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Sherron treats.

CMS data shows 4,080 Medicare services from Dr. Sherron across 20 procedure codes in 2024, for 810 Medicare patients. Medicare paid $476,540 for them.

CMS counts 810 Medicare patients who saw Dr. Sherron in 2024. The largest group is 65 to 74, with 416 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sherron's median patient age at 68, with 48% women.

In 2024, Dr. Sherron wrote 5,684 Medicare Part D claims for 691 patients. 78% of them were for generic drugs. CMS names the drug for 5,278 of them, across 63 drugs with 11 or more claims each, at $1,315,840 in total drug cost. In 2023, CMS named 4,621 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Sherron for performance year 2024, reported as part of a group. Dr. Sherron accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sherron as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Sherron, published from 2011 to 2014. 2011 was the busiest year, with 2. The most frequent topics are Electrocardiography, Coronary Angiography and Diagnostic Errors. Dr. Sherron's most frequent co-authors are Yochai Birnbaum, MD, Rajiv Goswami, DO and Henry Darchon Huang, MD.

CMS Open Payments shows 646 general payments to Dr. Sherron from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Resmed Corp paid the most, $1,200.

Dmand AI lists 3 awards for Dr. Sherron.

Dr. Sherron graduated from Joe R. & Teresa Lozano Long School of Medicine in 1988. Dr. Sherron is a member of ACC.

Dr. Sherron is in network with 20 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.